Tiate, Blessa Rose Q.
HRN: 23-80-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2023
METRONIDAZOLE 500MG (TAB)
12/20/2023
12/27/2023
PO
500 Mg
TID
S/P LSTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes